UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli

Antimicrobial Agents and Chemotherapy, 2004-09, Vol.48 (9), p.3621-3624

2004

Volltextzugriff (PDF)

Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex

Journal of antimicrobial chemotherapy, 2000-10, Vol.46 (4), p.571-576

2000

Volltextzugriff (PDF)

Novelties in the Field of Anti-infectives in 1997

Clinical infectious diseases, 1998-10, Vol.27 (4), p.865-883

BRYSKIER, A

1998

Volltextzugriff (PDF)

Effects of Various Media on the Activity of NXL103 (Formerly XRP 2868), a New Oral Streptogramin, against Haemophilus influenzae

Antimicrobial Agents and Chemotherapy, 2006-11, Vol.50 (11), p.3914-3916

2006

Volltextzugriff (PDF)

Cephems: Fifty Years of Continuous Research

The Journal of Antibiotics, 2000/10/25, Vol.53(10), pp.1028-1037

BRYSKIER, ANDRÉ

2000

Volltextzugriff (PDF)

Comparative In Vitro Activities of XRP 2868, Pristinamycin, Quinupristin-Dalfopristin, Vancomycin, Daptomycin, Linezolid, Clarithromycin, Telithromycin, Clindamycin, and Ampicillin against Anaerobic Gram-Positive Species, Actinomycetes, and Lactobacilli

Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.408-413

2005

Volltextzugriff (PDF)

Comparison of the in vitro efficacy of telithromycin (HMR 3647) and levofloxacin with 22 antibiotic compounds against Bosea and Afipia species

Journal of antimicrobial chemotherapy, 2004-04, Vol.53 (4), p.683-685

2004

Volltextzugriff (PDF)

In Vitro Activity of the New Ketolide Telithromycin Compared with Those of Macrolides against Streptococcus pyogenes: Influences of Resistance Mechanisms and Methodological Factors

Antimicrobial Agents and Chemotherapy, 2000-11, Vol.44 (11), p.2999-3002

2000

Volltextzugriff (PDF)

Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.489-493

2003

Volltextzugriff (PDF)

Activities of a New Oral Streptogramin, XRP 2868, Compared to Those of Other Agents against Streptococcus pneumoniae and Haemophilus Species

Antimicrobial Agents and Chemotherapy, 2003-10, Vol.47 (10), p.3270-3274

2003

Volltextzugriff (PDF)

In Vitro Activities of a New Lipopeptide, HMR 1043, against Susceptible and Resistant Gram-Positive Isolates

Antimicrobial Agents and Chemotherapy, 2003-09, Vol.47 (9), p.3025-3029

2003

Volltextzugriff (PDF)

New research in macrolides and ketolides since 1997

Expert opinion on investigational drugs, 1999-08, Vol.8 (8), p.1171-1194

Bryskier, André

1999

Volltextzugriff (PDF)

Activities of a New Fluoroketolide, HMR 3787, and Its (Des)-Fluor Derivative RU 64399 Compared to Those of Telithromycin, Erythromycin A, Azithromycin, Clarithromycin, and Clindamycin against Macrolide-Susceptible or -Resistant Streptococcus pneumoniae and S. pyogenes

Antimicrobial Agents and Chemotherapy, 2001-11, Vol.45 (11), p.3242-3245

2001

Volltextzugriff (PDF)

Activities of HMR 3787 and RU 64399 Compared with Those of Four Other Agents against Haemophilus influenzae and Haemophilus parainfluenzae

Antimicrobial Agents and Chemotherapy, 2003-01, Vol.47 (1), p.405-407

2003

Volltextzugriff (PDF)

Novelties in the Field of Anti-Infective Compounds in 1999

Clinical infectious diseases, 2000-12, Vol.31 (6), p.1423-1466

Bryskier, André

2000

Volltextzugriff (PDF)

In Vitro Activities of the New Ketolide Antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany

Antimicrobial Agents and Chemotherapy, 1998-06, Vol.42 (6), p.1509-1511

1998

Volltextzugriff (PDF)

Clonal Relatedness of Erythromycin-Resistant Streptococcus pyogenes Isolates in Germany

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1369-1373

2004

Volltextzugriff (PDF)

In Vitro Activities of the Ketolides Telithromycin (HMR 3647) and HMR 3004 Compared to Those of Clarithromycin against Slowly Growing Mycobacteria at pHs 6.8 and 7.4

Antimicrobial Agents and Chemotherapy, 2000-10, Vol.44 (10), p.2848-2852

2000

Volltextzugriff (PDF)

Antimicrobial activity of faropenem, a new oral penem, against lower respiratory tract pathogens

Clinical microbiology and infection, 1999-05, Vol.5 (5), p.282-287

1999

Volltextzugriff (PDF)

Novelties in the Field of Anti-Infectives in 1998

Clinical infectious diseases, 1999-09, Vol.29 (3), p.632-658

BRYSKIER, A

1999

Volltextzugriff (PDF)

Anti-anaerobic activity of antibacterial agents

Expert opinion on investigational drugs, 2001-02, Vol.10 (2), p.239-267

Bryskier, André

2001

Volltextzugriff (PDF)

Classification and structure-activity relationships of fluoroquinolones

Drugs (Basel), 1995, Vol.49 (Supplement 2), p.16-28

1995

Volltextzugriff (PDF)

In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis

Antimicrobial agents and chemotherapy, 2000-05, Vol.44 (5), p.1391-1393

2000

Volltextzugriff (PDF)

Anti-MRSA agents: under investigation, in the exploratory phase and clinically available

Expert review of anti-infective therapy, 2005-08, Vol.3 (4), p.505-553

Bryskier, André

2005

Volltextzugriff (PDF)

In Vitro Susceptibilities of Bordetella pertussis and Bordetella parapertussis to Two Ketolides (HMR 3004 and HMR 3647), Four Macrolides (Azithromycin, Clarithromycin, Erythromycin A, and Roxithromycin), and Two Ansamycins (Rifampin and Rifapentine)

Antimicrobial Agents and Chemotherapy, 1998-04, Vol.42 (4), p.965-966

1998

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Microbiology
(31)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Pharmacology & Pharmacy
(29)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(28)
Pharmacology. Drug Treatments
(28)
Humans
(25)
Anti-Bacterial Agents - Pharmacology
(24)
Antibacterial Agents
(22)
Microbial Sensitivity Tests
(20)
Ketolides
(18)
Anti-Bacterial Agents
(17)
Macrolides
(16)
Susceptibility
(13)
Infectious Diseases
(11)
Erythromycin - Pharmacology
(8)
Animals
(7)
Anti-Bacterial Agents - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli

Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex

Novelties in the Field of Anti-infectives in 1997

Effects of Various Media on the Activity of NXL103 (Formerly XRP 2868), a New Oral Streptogramin, against Haemophilus influenzae

Cephems: Fifty Years of Continuous Research

Comparative In Vitro Activities of XRP 2868, Pristinamycin, Quinupristin-Dalfopristin, Vancomycin, Daptomycin, Linezolid, Clarithromycin, Telithromycin, Clindamycin, and Ampicillin against Anaerobic Gram-Positive Species, Actinomycetes, and Lactobacilli

Comparison of the in vitro efficacy of telithromycin (HMR 3647) and levofloxacin with 22 antibiotic compounds against Bosea and Afipia species

In Vitro Activity of the New Ketolide Telithromycin Compared with Those of Macrolides against Streptococcus pyogenes: Influences of Resistance Mechanisms and Methodological Factors

Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001

Activities of a New Oral Streptogramin, XRP 2868, Compared to Those of Other Agents against Streptococcus pneumoniae and Haemophilus Species

In Vitro Activities of a New Lipopeptide, HMR 1043, against Susceptible and Resistant Gram-Positive Isolates

New research in macrolides and ketolides since 1997

Activities of a New Fluoroketolide, HMR 3787, and Its (Des)-Fluor Derivative RU 64399 Compared to Those of Telithromycin, Erythromycin A, Azithromycin, Clarithromycin, and Clindamycin against Macrolide-Susceptible or -Resistant Streptococcus pneumoniae and S. pyogenes

Activities of HMR 3787 and RU 64399 Compared with Those of Four Other Agents against Haemophilus influenzae and Haemophilus parainfluenzae

Novelties in the Field of Anti-Infective Compounds in 1999

In Vitro Activities of the New Ketolide Antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany

Clonal Relatedness of Erythromycin-Resistant Streptococcus pyogenes Isolates in Germany

In Vitro Activities of the Ketolides Telithromycin (HMR 3647) and HMR 3004 Compared to Those of Clarithromycin against Slowly Growing Mycobacteria at pHs 6.8 and 7.4

Antimicrobial activity of faropenem, a new oral penem, against lower respiratory tract pathogens

Novelties in the Field of Anti-Infectives in 1998

Anti-anaerobic activity of antibacterial agents

Classification and structure-activity relationships of fluoroquinolones

In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis

Anti-MRSA agents: under investigation, in the exploratory phase and clinically available

In Vitro Susceptibilities of Bordetella pertussis and Bordetella parapertussis to Two Ketolides (HMR 3004 and HMR 3647), Four Macrolides (Azithromycin, Clarithromycin, Erythromycin A, and Roxithromycin), and Two Ansamycins (Rifampin and Rifapentine)

Suchergebnisse filtern